EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut-Microbiota, and Multiple Sclerosis: Background, Evidence, and Perspectives

Clelia Altieri iD, Barbara Speranza iD, Maria Rosaria Corbo iD, Milena Sinigaglia, Antonio Bevilacqua iD

Nutrients · 2023

DOI: 10.3390/nu15040942 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2023. Verfasst von Clelia Altieri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Agriculture, Food, Natural Resources and Engineering (DAFNE), University of Foggia, 71122 Foggia, Italy. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Multiple Sclerosis, Microbiota, Probiotics. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Many scientific studies reveal a significant connection between human intestinal microbiota, eating habits, and the development of chronic-degenerative diseases; therefore, alterations in the composition and function of the microbiota may be accompanied by different chronic inflammatory mechanisms. Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS), in which autoreactive immune cells attack the myelin sheaths of the neurons. The purpose of this paper was to describe the main changes that occur in the gut microbiota of MS patients, with a focus on both microbiota and its implications for health and disease, as well as the variables that influence it. Another point stressed by this paper is the role of microbiota as a triggering factor to modulate the responses of the innate and adaptive immune systems, both in the intestine and in the brain. In addition, a comprehensive overview of the taxa modified by the disease is presented, with some points on microbiota modulation as a therapeutic approach for MS. Finally, the significance of gastro-intestinal pains (indirectly related to dysbiosis) was assessed using a case study (questionnaire for MS patients), as was the willingness of MS patients to modulate gut microbiota with probiotics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeMultiple SclerosisMicrobiotaProbioticsHumansIntestinesInflammationDysbiosis

Stichwörter der Autor:innen

dietdysbiosisgut microbiotamultiple sclerosisprobiotics

Autor:innen und Institutionen

  • Department of Agriculture, Food, Natural Resources and Engineering (DAFNE), University of Foggia, 71122 Foggia, Italy.

ORCID-Profile: Clelia Altieri, Barbara Speranza, Maria Rosaria Corbo, Antonio Bevilacqua

Zitieren

APA

Altieri, C., Speranza, B., Corbo, M. R., Sinigaglia, M., & Bevilacqua, A. (2023). Gut-Microbiota, and Multiple Sclerosis: Background, Evidence, and Perspectives. Nutrients. https://doi.org/10.3390/nu15040942

Vancouver

Altieri C, Speranza B, Corbo MR, Sinigaglia M, Bevilacqua A. Gut-Microbiota, and Multiple Sclerosis: Background, Evidence, and Perspectives. Nutrients. 2023. doi:10.3390/nu15040942

BibTeX
@article{Altieri2023,
  author = {Altieri, Clelia and Speranza, Barbara and Corbo, Maria Rosaria and Sinigaglia, Milena and Bevilacqua, Antonio},
  title = {Gut-Microbiota, and Multiple Sclerosis: Background, Evidence, and Perspectives},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15040942}
}
Kostenlos starten →